Glaxosmithkline Consumer Healthcare Holdings recalls Childrens Robitussin Honey Cough and Chest Congestion DM, dextromethorphan (cough suppressant), guaifenesin (expectoran…
- Recall date
- June 16, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1361-2020
- FDA classification
- Class II
- Brand / firm
- Glaxosmithkline Consumer Healthcare Holdings
- Sold / distributed
- Nationwide in the US
Why it was recalled
Defective Delivery System: the dosing cups are missing graduations applicable to certain age groups.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Childrens Robitussin Honey Cough and Chest Congestion DM, dextromethorphan (cough suppressant), guaifenesin (expectorant), 4 FL OZ. bottle (118 mL), Distributed by: Pfizer, Madison, NJ 07940 USA, UPC: 50300318760128, NDC: 0031-8760-12.
Get recall alerts
Free email alert whenever Glaxosmithkline Consumer Healthcare Holdings has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Glaxosmithkline Consumer Healthcare Holdings